Periventricular leukomalacia (PVL) is a term reserved to describe white matter injury in the premature brain. In this review article, the authors highlight the common and rare pathologies mimicking the chronic stage of PVL and propose practical clinico-radiological criteria that would aid in diagnosis and management.
Methods and Results:
The authors first describe the typical brain MRI (magnetic resonance imaging) features of PVL. Based on their clinical presentation, pathologic entities and their neuroimaging findings were clustered into distinct categories. Three clinical subgroups were identified: healthy children, children with stable/nonprogressive neurological disorder, and those with progressive neurological disorder. The neuroradiological discriminators are described in each subgroup with relevant differential diagnoses. The mimics were broadly classified into normal variants, acquired, and inherited disorders.
Conclusions:
The term “PVL” should be used appropriately as it reflects its pathomechanism. The phrase “white matter injury of prematurity” or “brain injury of prematurity” is more specific. Discrepancies in imaging and clinical presentation must be tread with caution and warrant further investigations to exclude other possibilities.
KinneyHCVolpeJJ. Encephalopathy of prematurity: neuropathology. In: VolpeJJInderTEDarrasBT, et al. eds. Volpe’s Neurology of the Newborn (Sixth Edition). Elsevier; 2018:389–404.
2.
VolpeJJ. Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances. Lancet Neurol. 2009;8(1):110–124.
3.
VolpeJJ. Systemic inflammation, oligodendroglial maturation, and the encephalopathy of prematurity. Ann Neurol. 2011;70(4):525–529.
4.
BarkovichARaybaudC. Pediatric Neuroimaging. Lippincott Williams & Wilkins; 2012.
5.
VolpeJJ.Hypoxic-ischemic encephalopathy: neuropathology and pathogenesis. In: Neurology of the Newborn. Elsevier; 2001. https://ci.nii.ac.jp/naid/10015436283/
6.
NeilJJVolpeJJ. Encephalopathy of prematurity: clinical-neurological features, diagnosis, imaging, prognosis, therapy. In: VolpeJJInderTEDarrasBT, et al. eds. Volpe’s Neurology of the Newborn (Sixth Edition). Elsevier; 2018:425–457.
7.
MarretSMukendiRGadisseuxJFGressensPEvrardP. Effect of ibotenate on brain development: an excitotoxic mouse model of microgyria and posthypoxic-like lesions. J Neuropathol Exp Neurol. 1995;54(3):358–370.
8.
Van HaastertICGroenendaalFUiterwaalCSPM, et al.Decreasing incidence and severity of cerebral palsy in prematurely born children. J Pediatr. 2011;159(1):86–91.e1.
9.
FavraisGvan de LooijYFleissB, et al.Systemic inflammation disrupts the developmental program of white matter. Ann Neurol. 2011;70(4):550–565.
10.
BackSAVolpeJJ. Encephalopathy of prematurity: pathophysiology. In: VolpeJJInderTEDarrasBT, et al. eds. Volpe’s Neurology of the Newborn (Sixth Edition). Elsevier; 2018:405–424.
11.
FernR. Ischemia: astrocytes show their sensitive side. Prog Brain Res. 2001;132:405–411.
12.
RaybaudC. The corpus callosum, the other great forebrain commissures, and the septum pellucidum: anatomy, development, and malformation. Neuroradiology. 2010;52(6):447–477.
ZaghloulNAhmedM. Pathophysiology of periventricular leukomalacia: what we learned from animal models. Neural Regeneration Res. 2017;12(11):1795–1796.
15.
VolpeJJ. The encephalopathy of prematurity—brain injury and impaired brain development inextricably intertwined. Semin Pediatr Neurol. 2009;16(4):167–178.
16.
VesoulisZAInderTEWoodwardLJBuseBVavasseurCMathurAM. Early electrographic seizures, brain injury, and neurodevelopmental risk in the very preterm infant. Pediatr Res. 2014;75(4):564–569.
17.
LeeRWPorettiACohenJS, et al.A diagnostic approach for cerebral palsy in the genomic era. Neuromolecular Med. 2014;16(4):821–844.
18.
ShangQMaC-YLvN, et al.Clinical study of cerebral palsy in 408 children with periventricular leukomalacia. Exp Ther Med. 2015;9(4):1336–1344.
19.
DiadoriP. Cerebral dysgenesis: embryology and clinical expression. 1992. By HarveyB. Sarnat. Published by Oxford University Press. 473 pages. SCDN 105.00. Can J Neurol Sci. 1995;22(1):77–77.
20.
VolpeJJ. Confusions in nomenclature: “periventricular leukomalacia” and “white matter injury”—identical, distinct, or overlapping?Pediatr Neurol. 2017;73:3–6.
21.
PiersonCRFolkerthRDBilliardsSS, et al.Gray matter injury associated with periventricular leukomalacia in the premature infant. Acta Neuropathol. 2007;114(6):619–631.
22.
LasryOShevellMIDagenaisL, REPACQ Consortium. Cross-sectional comparison of periventricular leukomalacia in preterm and term children. Neurology. 2010;74(17):1386–1391.
23.
MillerSPShevellMIPatenaudeYO’GormanAM. Neuromotor spectrum of periventricular leukomalacia in children born at term. Pediatr Neurol. 2000;23(2):155–159.
24.
KirtonAArmstrong-WellsJChangT, et al.Symptomatic neonatal arterial ischemic stroke: the International Pediatric Stroke Study. Pediatrics. 2011;128(6): e1402–e1410.
25.
LiauwLvan der GrondJSlooffV, et al.Differentiation between peritrigonal terminal zones and hypoxic-ischemic white matter injury on MRI. Eur J Radiol. 2008;65(3):395–401. doi:10.1016/j.ejrad.2007.04.016
26.
YakovlevPLLecoursAR. The myelogenetic cycles of regional maturation of the brain. In: MinkowskiA., ed. Regional Development of the Brain in Early Life. Blackwell; 3–70.
27.
YeomJSKimY-SSeoJ-H, et al.Distinctive pattern of white matter injury in neonates with rotavirus infection. Neurology. 2015;84(1):21–27.
28.
MariaAVallamkondaNShuklaABhattASachdevN. Encephalitic presentation of neonatal chikungunya: a case series. Indian Pediatr. 2018;55(8):671–674.
29.
Verboon-MaciolekMAGroenendaalFHahnCD, et al.Human parechovirus causes encephalitis with white matter injury in neonates. Ann Neurol. 2008;64(3):266–273.
30.
MorrissFHJrLindowerJBBartlettHL, et al.Neonatal enterovirus infection: case series of clinical sepsis and positive cerebrospinal fluid polymerase chain reaction test with myocarditis and cerebral white matter injury complications. AJP Rep. 2016;6(3): e344–e351.
Verboon-MaciolekMAGroenendaalFCowanFGovaertPvan LoonAMde VriesLS. White matter damage in neonatal enterovirus meningoencephalitis. Neurology. 2006;66(8):1267–1269. doi:10.1212/01.wnl.0000208429.69676.23
33.
VolpeJJ. Neonatal encephalitis and white matter injury: more than just inflammation?Ann Neurol. 2008;64(3):232–236.
34.
KirtonAShroffMPontigonA-MdeVeberG. Risk factors and presentations of periventricular venous infarction vs arterial presumed perinatal ischemic stroke. Arch Neurol. 2010;67(7). doi:10.1001/archneurol.2010.140
35.
ArrigoniFParazziniCRighiniA, et al.Deep medullary vein involvement in neonates with brain damage: an MR imaging study. AJNR Am J Neuroradiol. 2011;32(11):2030–2036.
36.
MankadKBiswasAEspagnetMCR, et al.Venous pathologies in paediatric neuroradiology: from foetal to adolescent life. Neuroradiology. November9, 2019. doi:10.1007/s00234-019-02294-x.
37.
Abou-HamdenADrakeJM. Hydrocephalus and arachnoid cysts. In SwaimanKFAshwalSFerrieroDM, et al. eds. Swaiman’s Pediatric Neurology. Elsevier; 2017:226–232.
38.
McMullanPJRomanowskiCAJ. Radiological assessment of hydrocephalus treatment and treatment-related complications. Clin Neuroradiol. 2019:579–597. doi:10.1007/978-3-319-68536-6_15.
39.
AkbariSHALimbrickDDMcKinstryRC, et al.Periventricular hyperintensity in children with hydrocephalus. Pediatr Radiol. 2015;45(8):1189–1197. doi:10.1007/s00247-015-3298-8.
40.
AbbottREpsteinFJWisoffJH. Chronic headache associated with a functioning shunt: usefulness of pressure monitoring. Neurosurgery. 1991;28(1):72–76; discussion 76-77.
41.
KortümFJamraRAAlawiM, et al.Clinical and genetic spectrum of AMPD2-related pontocerebellar hypoplasia type 9. Eur J Hum Genet. 2018;26(5):695–708.
ScolaEGanauMRobinsonR, et al.Neuroradiological findings in three cases of pontocerebellar hypoplasia type 9 due to mutation: typical MRI appearances and pearls for differential diagnosis. Quant Imaging Med Surg. 2019;9(12):1966–1972.
44.
MeuwissenMECHalleyDJJSmitLS, et al.The expanding phenotype of COL4A1 and COL4A2 mutations: clinical data on 13 newly identified families and a review of the literature. Genet Med. 2015;17(11):843–853.
45.
ShahSEllardSKneenR, et al.Childhood presentation of COL4A1 mutations. Dev Med Child Neurol. 2012;54(6):569–574.
46.
FaberIServelhereKRMartinezARMLopes-CendesIFrançaMCJrOthers. Clinical features and management of hereditary spastic paraplegia. Arq Neuropsiquiatr. 2014;72(3):219–226.
47.
GaraciFToschiNLanzafameS, et al.Diffusion tensor imaging in SPG11- and SPG4-linked hereditary spastic paraplegia. Int J Neurosci. 2014;124(4):261–270. doi:10.3109/00207454.2013.836705
48.
GraçaFFda, da GraçaFFde RezendeTJR, et al.Neuroimaging in hereditary spastic paraplegias: current use and future perspectives. Front Neurol. 2019;9. doi:10.3389/fneur.2018.01117.
49.
Ebrahimi-FakhariDTeinertJBehneR, et al.Defining the clinical, molecular and imaging spectrum of adaptor protein complex 4-associated hereditary spastic paraplegia. Brain. 2020;143(10):2929–2944.
50.
KamateMDetrojaM. Clinico-investigative profile of hereditary spastic paraplegia in children. Ann Indian Acad Neurol. 2019;22(3):341.
51.
ChongJXCaputoVPhelpsIG, et al.Recessive inactivating mutations in TBCK, encoding a rab GTPase-activating protein, cause severe infantile syndromic encephalopathy. Am J Hum Genet. 2016;98(4):772–781.
52.
Beck-WödlSHarzerKSturmM, et al.Homozygous TBC1 domain-containing kinase (TBCK) mutation causes a novel lysosomal storage disease—a new type of neuronal ceroid lipofuscinosis (CLN15)?Acta Neuropathol Commun. 2018;6(1). doi:10.1186/s40478-018-0646-6.
53.
Ortiz-GonzálezXRTintos-HernándezJAKellerK, et al.Homozygous boricua TBCK mutation causes neurodegeneration and aberrant autophagy. Ann Neurol. 2018;83(1):153–165.
54.
SainiAGSinghiP. Infantile metabolic encephalopathy due to fumarase deficiency. J Child Neurol. 2013;28(4):535–537.
55.
KerriganJFAleckKATarbyTJBirdCRHeidenreichRA. Fumaric aciduria: clinical and imaging features. Ann Neurol. 2000;47(5):583–588.
56.
GropmanAL. Neuroimaging in mitochondrial disorders. Neurotherapeutics. 2013;10(2):273–285.
57.
SanetoRPFriedmanSDShawDWW. Neuroimaging of mitochondrial disease. Mitochondrion. 2008;8(5-6):396–413.
58.
AlvesCAPFGonçalvesFGGriebDLucatoLTGoldsteinACZuccoliG. Neuroimaging of mitochondrial cytopathies. Top Magn Reson Imaging. 2018;27(4):219–240.
59.
MenezesMJRileyLGChristodoulouJ. Mitochondrial respiratory chain disorders in childhood: insights into diagnosis and management in the new era of genomic medicine. Biochim Biophys Acta. 2014;1840(4):1368–1379.
60.
MoslemiA-RDarinN. Molecular genetic and clinical aspects of mitochondrial disorders in childhood. Mitochondrion. 2007;7(4):241–252.
61.
KoenigMK. Presentation and diagnosis of mitochondrial disorders in children. Pediatr Neurol. 2008;38(5):305–313.
62.
ThieleEAKorfBR. Phakomatoses and allied conditions. In: SwaimanKFAshwalSFerrieroDM, et al. eds. Swaiman’s Pediatric Neurology. Elsevier; 2017:362–372.
63.
FigueiredoACPCTMata-MachadoNMcCoydMBillerJ. Neurocutaneous disorders for the practicing neurologist: a focused review. Curr Neurol Neurosci Rep. 2016;16(2):19.
64.
Van der KnaapMSValkJ. Magnetic Resonance of Myelination and Myelin Disorders. Springer; 2005.
Soltirovska SalamonALichtenbeltKCowanFM, et al.Clinical presentation and spectrum of neuroimaging findings in newborn infants with incontinentia pigmenti. Dev Med Child Neurol. 2016;58(10):1076–1084.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
